Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taff Jones

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|September 26, 2003
ChimeriVax-JE. AcambisTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Resiquimod 3MTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|July 31, 2008
Respiration consists of two acts: first inspiration, then expect(or)ationTaff Jones
Expert Review of Vaccines|June 5, 2004
A chimeric live attenuated vaccine against Japanese encephalitisTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|September 8, 2006
Vaccines against human papilloma virusesTaff Jones
Current Opinion in Molecular Therapeutics|January 27, 2009
IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infectionTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Remune. Immune ResponseDerhsing Lai, Taff Jones
Proceedings of the Royal Society of London. Series B, Biological Sciences|December 4, 1978
Morphology and molecular composition of isolated postsynaptic junctional structuresA I Matus, D H Taff-Jones
Vaccine|September 25, 2012
The role of nasal IgA in children vaccinated with live attenuated influenza vaccineChristopher S Ambrose, Xionghua Wu, Taff Jones, et al.
Vaccine|March 22, 2007
C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccineSonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Current Opinion in Investigational Drugs (London, England : 2000)|September 26, 2003
ChimeriVax-JE. AcambisTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|April 3, 2003
Resiquimod 3MTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|July 31, 2008
Respiration consists of two acts: first inspiration, then expect(or)ationTaff Jones
Expert Review of Vaccines|June 5, 2004
A chimeric live attenuated vaccine against Japanese encephalitisTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|September 8, 2006
Vaccines against human papilloma virusesTaff Jones
Current Opinion in Molecular Therapeutics|January 27, 2009
IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infectionTaff Jones
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Remune. Immune ResponseDerhsing Lai, Taff Jones
Proceedings of the Royal Society of London. Series B, Biological Sciences|December 4, 1978
Morphology and molecular composition of isolated postsynaptic junctional structuresA I Matus, D H Taff-Jones
Vaccine|September 25, 2012
The role of nasal IgA in children vaccinated with live attenuated influenza vaccineChristopher S Ambrose, Xionghua Wu, Taff Jones, et al.
Vaccine|March 22, 2007
C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccineSonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Pageof 3